EUVIMEDEUVIMED entdecken
Querschnittstudie

The increase in TDP-43 and neurogranin blood levels at different stages of cognitive impairment in the elderly people: A cross-sectional study

Aleksandra Ochneva iD, Valeriya Zakurazhnaya iD, Yana Zorkina, Olga Abramova iD, Valeriya Ushakova, Anna Tsurina, Elizaveta Golubeva iD, Olga Gurina, Aleksandr Berdalin, Timur Sunyakov, Alisa Andryushchenko, Marat Kurmyshev und 6 weitere

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251350385 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Aleksandra Ochneva und 17 weiteren Autor:innen. Beteiligte Einrichtung: Mental-health Clinic No. 1 named after N.A. Alexeev, Moscow, Russia. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Neurogranin, DNA-Binding Proteins. Die Arbeit nennt 115 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD), a neurodegenerative condition and major subtype of dementia, is often preceded by mild cognitive impairment (MCI), a transitional stage before dementia. While cerebrospinal fluid (CSF) biomarkers are widely used for diagnosing AD and MCI, blood-based biomarkers offer the advantage of easier accessibility. This study aimed to compare blood levels of nine biomarkers among healthy controls, patients with MCI, and those with dementia, and to evaluate their potential for predicting AD progression.

Objective

The aim of our study was to study biomarkers in three groups of elderly people with varying degrees of cognitive decline.

Methods

The study included 234 participants aged 65 and older with dementia, MCI, or no cognitive impairment. Cognitive function was assessed using the Mini-Mental State Examination scale. Plasma levels of nine biomarkers, including amyloid-β 40 (Aβ 40 ), amyloid-β 42 (Aβ 42 ), KLK-6, NCAM-1, FGF-21, neurogranin, Tau, pTau181, and TDP-43, were measured by multiplex analysis.

Results

Aβ 42 levels were higher in the MCI group compared to controls (p = 0.002) and in dementia patients compared to those with MCI (p = 0.018). TDP-43 and neurogranin levels were elevated in dementia patients compared to both the MCI group (p < 0.05 and p < 0.01, respectively) and controls (p < 0.05 and p < 0.001, respectively). Neurogranin levels were also higher in the MCI group compared to controls (p < 0.001) and significantly differed between MCI and dementia (p = 0.003).

Conclusions

Aβ 42 , TDP-43, and neurogranin show potential as blood-based biomarkers for cognitive decline and may provide insight into the pathogenesis of neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionNeurograninDNA-Binding ProteinsHumansAgedMaleFemaleCross-Sectional StudiesBiomarkersAmyloid beta-PeptidesAged, 80 and overPeptide FragmentsDisease ProgressionMental Status and Dementia TestsNeuropsychological Tests

Stichwörter der Autor:innen

Alzheimer's diseaseTDP-43blood biomarkersdementiamild cognitive impairmentneurogranin

Substanzen

NeurograninBiomarkersDNA-Binding ProteinsAmyloid beta-PeptidesTARDBP protein, humanPeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • Mental-health Clinic No. 1 named after N.A. Alexeev, Moscow, Russia.
  • V. Serbsky National Medical Research Centre of Psychiatry and Narcology, Moscow, Russia.
  • A.S. Loginov Moscow Clinical Scientific Centre, Moscow, Russia.
  • Russian Medical Academy of Continuous Professional Education, Moscow, Russia.
  • M. V. Lomonosov Moscow State University, Moscow, Russia.
  • Federal State Budgetary Educational Institution of Higher Education Russian Biotechnological University, Moscow, Russia.

ORCID-Profile: Aleksandra Ochneva, Valeriya Zakurazhnaya, Olga Abramova, Elizaveta Golubeva

Zitieren

APA

Ochneva, A., Zakurazhnaya, V., Zorkina, Y., Abramova, O., Ushakova, V., Tsurina, A., Golubeva, E., Gurina, O., Berdalin, A., Sunyakov, T., Andryushchenko, A., Kurmyshev, M., Kagramanova, A., Shinkin, M., Fadeeva, N., Bodunova, N., Kostyuk, G., & Morozova, A. (2025). The increase in TDP-43 and neurogranin blood levels at different stages of cognitive impairment in the elderly people: A cross-sectional study. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251350385

Vancouver

Ochneva A, Zakurazhnaya V, Zorkina Y, Abramova O, Ushakova V, Tsurina A, et al. The increase in TDP-43 and neurogranin blood levels at different stages of cognitive impairment in the elderly people: A cross-sectional study. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251350385

BibTeX
@article{Ochneva2025,
  author = {Ochneva, Aleksandra and Zakurazhnaya, Valeriya and Zorkina, Yana and Abramova, Olga and Ushakova, Valeriya and Tsurina, Anna and Golubeva, Elizaveta and Gurina, Olga and Berdalin, Aleksandr and Sunyakov, Timur and Andryushchenko, Alisa and Kurmyshev, Marat and Kagramanova, Anna and Shinkin, Mikhail and Fadeeva, Nina and Bodunova, Natalia and Kostyuk, Georgiy and Morozova, Anna},
  title = {The increase in TDP-43 and neurogranin blood levels at different stages of cognitive impairment in the elderly people: A cross-sectional study},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251350385}
}
Kostenlos starten →